Australian first research trial to explore use of psychedelics for alcohol use disorder

Researchers at the University of Sydney are embarking on an Australian first research trial into the use of psychedeli...

December 22, 2022 | Thursday | News
Singapore identifies new therapeutic target for treating diabetic eye disease

Singapore researchers have discovered a novel therapeutic target named ADAM10 that could be used to treat patients ...

December 23, 2022 | Friday | News
Researchers at Australia & Korea investigate effect of COVID-19 virus on vision

A study, co-led by Australia-based Griffith University’s Menzies Health Institute and South Korea’s Center f...

December 20, 2022 | Tuesday | News
Singapore identifies predictive blood biomarker for cognitive impairment and dementia

A recent study by a team comprising researchers from the National University of Singapore (NUS) and the National Univers...

December 21, 2022 | Wednesday | News
Hong Kong develops new aptamer drug for bone anabolic therapies

A research team led by Hong Kong Baptist University (HKBU) has identified a molecular target for bone amabolic therapies...

December 19, 2022 | Monday | News
Japanese firm Eisai partners with Washington University for treatment of neuro diseases

Eisai and Washington University School of Medicine in St. Louis have entered into a comprehensive research collaboration...

December 19, 2022 | Monday | News
Trial of ultrasound treatment for Alzheimer’s underway in Australia

A pioneering treatment for Alzheimer’s disease, developed at The University of Queensland (UQ) in Australia, is be...

December 13, 2022 | Tuesday | News
Singapore identifies gene that controls scarring in damaged hearts

Scientists at Duke-NUS Medical School in Singapore have identified a gene that controls the behaviour of a specific type...

December 12, 2022 | Monday | News
Hong Kong develops multifunctional nanoparticle for diagnosis & treatment of glioma

A Hong Kong Baptist University (HKBU) collaborative research team, along with researchers at Hong Kong Polytechnic ...

November 28, 2022 | Monday | News
Integrated stem cell solutions to combat rising degenerative diseases amongst Malaysians

According to the Department of Statistics Malaysia (DOSM), population with age 60 and above is increasing yearly and Mal...

November 25, 2022 | Friday | News
Korea inks MoU with US to establish precision medicine research platform

Seoul National University (SNU) Bundang Hospital Biomedical Research Institute has concluded a Memorandum of Understandi...

November 17, 2022 | Thursday | News
GSK invests S$44 M in manufacturing facility at Singapore for cancer treatment

The global biopharma company GSK plc has launched a new, S$44 million high potency facility (HPF) in its strategic New P...

November 17, 2022 | Thursday | Company results
Australia announces world first regulatory approval for donor derived microbiome drug

Australian startup BiomeBank has announced the first regulatory approval for a donor derived microbiome drug product wor...

November 9, 2022 | Wednesday | News
NZ-based startup develops eye drops to treat keratoconus

A new University of Auckland spin-out company, TheiaNova, is working to introduce a groundbreaking, non-invasive treatme...

November 8, 2022 | Tuesday | News
I Peace partners with the California Institute for Regenerative Medicine

Founded in 2015 by Koji Tanabe, a graduate of Professor Shinya Yamanaka's laboratory at Kyoto Univer...

November 3, 2022 | Thursday | News
Australia announces world-first brain cancer clinical trials

A world-first clinical trial platform launching in Melbourne is set to transform research into new therapies for brain c...

November 1, 2022 | Tuesday | News
“Accelerated ageing is associated with reduced diversification of the gut microbiome that further increases the risk of developing disease”

How would you describe your primary mission and vision of the Centre for Microbiome Medicine?  Microbiome is the l...

November 1, 2022 | Tuesday | Opinion
JW Therapeutics accelerates R&D of T cell-based immunotherapies in China

JW Therapeutics and 2seventy bio have announced a strategic alliance to establish a translational and clinical cell ther...

October 27, 2022 | Thursday | News